The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET

Structured PICO

Does the development of new onset anaemia increase morbidity and mortality in stable ambulatory CHF patients?

Population

Stable ambulatory chronic heart failure (CHF) patients

Intervention

Development of new onset anaemia (NOA) / decreases in hemoglobin (Hb) over time

Outcome

Morbidity and mortalityhard clinical

In stable ambulatory CHF patients, the development of new onset anemia is associated with increased future morbidity and mortality.

Abstract

In stable ambulatory CHF patients, development of NOA is frequent and can be predicted by a set of clinical variables. Decreases in Hb over time relate to future increased morbidity and mortality.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Komajda et al. (Mon,) studied this question.

synapsesocial.com/papers/69d959a85e5bcb4e3b835ae6 https://doi.org/https://doi.org/10.1093/eurheartj/ehl012

Bookmark

View Full Paper